CAR-T therapy is an advanced cancer treatment where a patient’s T-cells are genetically modified to express chimeric antigen receptors (CARs) that target and destroy cancer cells. As Dr. DEBORAH RATHJEN from Carina Biotech explains, this personalised immunotherapy has already shown promising results during clinical trials.